pembrolizumab adjuvant lung cancer

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
pembrolizumab adjuvant lung cancer	0.51	1	7573	91	34
pembrolizumab	1.74	0.7	5816	67	13
adjuvant	1.45	0.5	3960	90	8
lung	0.77	0.1	9435	21	4
cancer	0.37	0.2	6703	72	6

Keyword	CPC	PCC	Volume	Score
pembrolizumab adjuvant lung cancer	1.25	0.4	5279	20
pembrolizumab in lung cancer	1.1	1	3223	14
neoadjuvant pembrolizumab lung cancer	1.26	0.6	5803	35
pembrolizumab single agent lung cancer	0.97	0.8	5649	100
adjuvant pembrolizumab breast cancer	0.84	0.2	581	67
pembrolizumab chemotherapy lung cancer	0.21	0.3	8651	78
pembrolizumab lung cancer fda	0.86	0.1	7389	64
pembrolizumab metastatic lung cancer	0.17	0.2	8186	95
nejm pembrolizumab lung cancer	1.72	0.5	2895	92
pembrolizumab small cell lung cancer	1.43	0.5	2662	26
pembrolizumab adjuvant kidney cancer	0.41	0.8	4212	24
pembrolizumab lung cancer fda approval	1.75	0.9	8036	54
nivolumab and pembrolizumab for lung cancer	0.58	0.1	8076	68
pembrolizumab success rate lung cancer	0.11	0.2	5856	59
adjuvant pembrolizumab bladder cancer	0.36	0.6	9538	49
pembrolizumab for cancer patients	1.85	1	3390	64
pembrolizumab keynote metastatic lung cancer	0.51	0.9	4192	67
pembrolizumab neoadjuvant breast cancer	0.57	1	5853	23
adjuvant pembrolizumab renal cell carcinoma	1.43	0.1	2460	23
pembrolizumab a chemo drug	0.26	0.8	4775	72